These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 35348900)

  • 1. Nephrocalcinosis in very low birth weight infants: incidence, associated factors, and natural course.
    Fayard J; Pradat P; Lorthois S; Bacchetta J; Picaud JC
    Pediatr Nephrol; 2022 Dec; 37(12):3093-3104. PubMed ID: 35348900
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vitamin D, bone density, and nephrocalcinosis in preterm infants: a prospective study.
    Malone Jenkins S; Chan G; Weaver-Lewis K; Bardsley T; Felix J; Grinsell M
    Pediatr Nephrol; 2022 Jun; 37(6):1325-1332. PubMed ID: 34595571
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of nephrocalcinosis in very low birth weight infants.
    Hein G; Richter D; Manz F; Weitzel D; Kalhoff H
    Pediatr Nephrol; 2004 Jun; 19(6):616-20. PubMed ID: 15054644
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nephrocalcinosis in preterm infants: a single center experience.
    Hoppe B; Duran I; Martin A; Kribs A; Benz-Bohm G; Michalk DV; Roth B
    Pediatr Nephrol; 2002 Apr; 17(4):264-8. PubMed ID: 11956879
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypocitraturia is one of the major risk factors for nephrocalcinosis in very low birth weight (VLBW) infants.
    Sikora P; Roth B; Kribs A; Michalk DV; Hesse A; Hoppe B
    Kidney Int; 2003 Jun; 63(6):2194-9. PubMed ID: 12753307
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Etiology of nephrocalcinosis in preterm neonates: association of nutritional intake and urinary parameters.
    Schell-Feith EA; Kist-van Holthe JE; Conneman N; van Zwieten PH; Holscher HC; Zonderland HM; Brand R; van der Heijden BJ
    Kidney Int; 2000 Nov; 58(5):2102-10. PubMed ID: 11044231
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A case control analysis investigating risk factors and outcomes for nephrocalcinosis and renal calculi in neonates.
    Huynh M; Clark R; Li J; Filler G; Dave S
    J Pediatr Urol; 2017 Aug; 13(4):356.e1-356.e5. PubMed ID: 28821388
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exposure to furosemide as the strongest risk factor for nephrocalcinosis in preterm infants.
    Gimpel C; Krause A; Franck P; Krueger M; von Schnakenburg C
    Pediatr Int; 2010 Feb; 52(1):51-6. PubMed ID: 19460127
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nephrocalcinosis in pre-term neonates: a study of incidence and risk factors.
    Mohamed GB; Ibrahiem MA; Abdel Hameed WM
    Saudi J Kidney Dis Transpl; 2014 Mar; 25(2):326-32. PubMed ID: 24625999
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renal calcification in very low birth weight infants.
    Chang HY; Hsu CH; Tsai JD; Li ST; Hung HY; Kao HA; Chang JH; Chung HY; Wang HK
    Pediatr Neonatol; 2011 Jun; 52(3):145-9. PubMed ID: 21703556
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nephrocalcinosis in very low birth weight infants.
    Nasseri F; Azhir A; Rahmanian S; Iranpour R; Adibi A
    Saudi J Kidney Dis Transpl; 2010 Mar; 21(2):284-9. PubMed ID: 20228514
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nephrocalcinosis in very low birth weight infants: a single center experience.
    Ketkeaw K; Thaithumyanon P; Punnahitananda S
    J Med Assoc Thai; 2004 Sep; 87 Suppl 2():S72-7. PubMed ID: 16083166
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nephrocalcinosis in preterm babies.
    Narendra A; White MP; Rolton HA; Alloub ZI; Wilkinson G; McColl JH; Beattie J
    Arch Dis Child Fetal Neonatal Ed; 2001 Nov; 85(3):F207-13. PubMed ID: 11668166
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MOnitored supplementation of VItamin D in preterm infants (MOSVID trial): study protocol for a randomised controlled trial.
    Kołodziejczyk A; Borszewska-Kornacka MK; Seliga-Siwecka J
    Trials; 2017 Sep; 18(1):424. PubMed ID: 28893306
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The natural history of nephrocalcinosis in premature infants treated with loop diuretics.
    Pope JC; Trusler LA; Klein AM; Walsh WF; Yared A; Brock JW
    J Urol; 1996 Aug; 156(2 Pt 2):709-12. PubMed ID: 8683766
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nephrocalcinosis in preterm neonates.
    Schell-Feith EA; Kist-van Holthe JE; van der Heijden AJ
    Pediatr Nephrol; 2010 Feb; 25(2):221-30. PubMed ID: 18797936
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Etiology and prognosis of nephrocalcinosis according to gestational age in Korean children.
    Joung J; Cho H
    BMC Pediatr; 2023 Sep; 23(1):451. PubMed ID: 37684572
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors associated with nephrocalcinosis in preterm infants.
    Lee HS; Sung IK; Kim SJ; Youn YA; Lee JY; Lim GY; Im SA; Ku YM; Lee JH; Kim SY
    Am J Perinatol; 2014 Apr; 31(4):279-86. PubMed ID: 23733706
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nephrocalcinosis.
    Adams ND; Rowe JC
    Clin Perinatol; 1992 Mar; 19(1):179-95. PubMed ID: 1576767
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomized, controlled evaluation of two commercially available human breast milk fortifiers in healthy preterm neonates.
    Sankaran K; Papageorgiou A; Ninan A; Sankaran R
    J Am Diet Assoc; 1996 Nov; 96(11):1145-9. PubMed ID: 8906139
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.